Senior MSL – Alzheimer's Disease (Field-Based)

Eisai Co., Ltd. is a global pharmaceutical company headquartered in Japan. The company was founded in 1941 and has since been committed to discovering and developing innovative pharmaceuticals in the fields of neurology and oncology. Eisai operates in over 70 countries worldwide and is recognized for its dedication to improving the mental and physical health of patients through its research and development efforts.

With a focus on providing effective treatments, Eisai invests heavily in clinical trials and research projects, as well as collaborations with various academic and research institutions. Their motto, 'Taking on the Challenge of New Drug Discovery,' encapsulates their ambition and dedication towards addressing unmet medical needs, especially in the areas of Alzheimer’s disease and cancer. The company strives to contribute to society by working to provide value to patients and families, and to the medical community.